• 15078 Citations
  • 54 h-Index
1981 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1981 2019

Clinical Trials
Radiation Oncology
Translational Medical Research
Health Services Research
Genomic Instability
Breast Neoplasms
Phosphatidylinositol 3-Kinases
Breast Neoplasms
DNA Repair-Deficiency Disorders

Research Output 1989 2018

Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer

Telli, M. L., Stover, D. G., Loi, S., Aparicio, S., Carey, L. A., Domchek, S. M., Newman, L., Sledge, G. W. & Winer, E. P., May 7 2018, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-11 11 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Homologous Recombination
1 Citations

Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer

Nyrop, K. A., Deal, A. M., Choi, S. K., Wagoner, C. W., Lee, J. T., Wood, A., Anders, C., Carey, L. A., Dees, E. C., Jolly, T. A., Reeder-Hayes, K. E. & Muss, H. B., Feb 1 2018, In : Breast Cancer Research and Treatment. 168, 1, p. 43-55 13 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Linear Models

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

Freedman, R. A., Seisler, D. K., Foster, J. C., Sloan, J. A., Lafky, J. M., Kimmick, G. G., Hurria, A., Cohen, H. J., Winer, E. P., Hudis, C. A., Partridge, A. H., Carey, L. A., Jatoi, A., Klepin, H. D., Citron, M., Berry, D. A., Shulman, L. N., Buzdar, A. U., Suman, V. J. & Muss, H. B., Jan 1 2017, In : Breast Cancer Research and Treatment. 161, 2, p. 363-373 11 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Adjuvant Chemotherapy
Acute Myeloid Leukemia
Breast Neoplasms
203 Citations

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer

Tolaney, S. M., Barry, W. T., Dang, C. T., Yardley, D. A., Moy, B., Marcom, P. K., Albain, K. S., Rugo, H. S., Ellis, M., Shapira, I., Wolff, A. C., Carey, L. A., Overmoyer, B. A., Partridge, A. H., Guo, H., Hudis, C. A., Krop, I. E., Burstein, H. J. & Winer, E. P., Jan 8 2015, In : New England Journal of Medicine. 372, 2, p. 134-141 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Confidence Intervals
Disease-Free Survival
1 Citations

CCR 20th anniversary commentary: Simpson's paradox and neoadjuvant trials

Carey, L. A., Sep 15 2015, In : Clinical Cancer Research. 21, 18, p. 4027-4029 3 p.

Research output: Contribution to journalReview article

Anniversaries and Special Events
Neoadjuvant Therapy